Market context for this story
Loading quotes…
Informational only — not investment advice. Full markets →

Insider Moves: Artiva Biotherapeutics ($ARTV) — Director Receives Stock Award
💡 - The stock award (code A) is a compensation event, not a cash buy — no direct bullish or bearish signal from this transaction. - No ticker symbol was disclosed, so traders cannot directly gauge market price action around this insider move. - Watch for subsequent open-market purchases (code P) from insiders, which would indicate management's confidence in the company's prospects. - Without a ticker, avoid trading decisions based solely on this filing; seek other catalysts like clinical trial data or earnings reports.
Artiva Biotherapeutics, Inc. ($ARTV) filed a Form 4 with the SEC on July 23, 2026, detailing a stock award to a director. The transaction, coded as an award rather than an open-market purchase, does not directly signal insider conviction but adds to insider holdings.
(1) The trade — A director of Artiva Biotherapeutics received a stock award (transaction code A). The filing does not specify the number of shares or price per share. Code A indicates the insider was granted equity, not that they bought shares on the open market.
(2) Who — The insider is a director of Artiva Biotherapeutics, Inc., the issuer based in the United States.
(3) Ticker — The ticker symbol is not explicitly provided in the structured facts. Based on the company name and SEC filings, the ticker is not given; therefore, no symbol can be confirmed. For reference, the issuer's SEC CIK is 0001817241.
(4) Signal read — Because this is a grant (code A), it does not reflect an insider's discretionary purchase or sale. Awards are typically compensation or incentive-based and carry less market-moving signal than open-market buys or sales.
(5) What to watch — No cluster buying or unusual insider activity is indicated. Investors should monitor future Form 4 filings for open-market purchases (code P) or sales (code S) by directors or officers, which could offer stronger conviction signals.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Broker buttons use invite / refer-a-friend links (rewards may be capped). Other partner links may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →Curated tools and reads — shopping here helps keep OppHub America free.
Playbook
New stories get a playbook when they publish. Older articles may not have one yet.
No stored playbook for this article. Going forward, playbooks are generated once at publish and kept on the story.